Cortexyme Stock Short Ratio
Cortexyme fundamentals help investors to digest information that contributes to Cortexyme's financial success or failures. It also enables traders to predict the movement of Cortexyme Stock. The fundamental analysis module provides a way to measure Cortexyme's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cortexyme stock.
Cortexyme |
Cortexyme Company Short Ratio Analysis
Cortexyme's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Cortexyme Short Ratio | 29.06 X |
Most of Cortexyme's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cortexyme is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Cortexyme has a Short Ratio of 29.06 times. This is much higher than that of the Biotechnology sector and 292.17% higher than that of the Health Care industry. The short ratio for all United States stocks is notably lower than that of the firm.
Cortexyme Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cortexyme's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cortexyme could also be used in its relative valuation, which is a method of valuing Cortexyme by comparing valuation metrics of similar companies.Cortexyme is currently under evaluation in short ratio category among related companies.
Cortexyme Fundamentals
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.11 | ||||
| Current Valuation | (19.76 M) | ||||
| Shares Outstanding | 43.22 M | ||||
| Shares Owned By Insiders | 13.07 % | ||||
| Shares Owned By Institutions | 28.16 % | ||||
| Number Of Shares Shorted | 1.86 M | ||||
| Price To Book | 0.48 X | ||||
| EBITDA | (24.32 M) | ||||
| Net Income | (31.39 M) | ||||
| Cash And Equivalents | 94.66 M | ||||
| Cash Per Share | 2.62 X | ||||
| Total Debt | 13.81 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 16.70 X | ||||
| Book Value Per Share | 1.98 X | ||||
| Cash Flow From Operations | (18.29 M) | ||||
| Short Ratio | 29.06 X | ||||
| Earnings Per Share | (0.84) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 32 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 41.49 M | ||||
| Total Asset | 180.2 M | ||||
| Retained Earnings | (319.64 M) | ||||
| Working Capital | 67.87 M | ||||
| Net Asset | 180.2 M |
About Cortexyme Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cortexyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cortexyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cortexyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Cortexyme using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. Note that the Cortexyme information on this page should be used as a complementary analysis to other Cortexyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Tools for Cortexyme Stock
When running Cortexyme's price analysis, check to measure Cortexyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cortexyme is operating at the current time. Most of Cortexyme's value examination focuses on studying past and present price action to predict the probability of Cortexyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cortexyme's price. Additionally, you may evaluate how the addition of Cortexyme to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |